Researchers analyze platelet and neutrophil activation in COVID-19 patients and its association with venous thromboembolism.
Applying clinical prediction rules correctly when treating patients with venous thromboembolism in primary care was found to be associated with low failure rate.
A population-based analysis suggested that plasma levels of von Willebrand factor may be a potential biomarker for the future risk of incident venous thromboembolism.
Low-intensity warfarin therapy was found to be as effective as standard-intensity I warfarin in lowering the risk for thromboembolism in older patients with nonvalvular atrial fibrillation.
Expert consensus decision pathway for anticoagulant and antiplatelet use in patients with atherosclerotic cardiovascular disease or in those with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention.
A team of investigators examined the effect of a history of venous thromboembolism on recurrence of thrombosis in patients with cancer.
A novel diagnostic algorithm was able to safely rule out DVT in patients visiting an emergency department, thereby reducing the need for ultrasound imaging.
Patients with thromboembolism have increased pooled odds of mortality compared to those without.
A Japanese study examined the association among pulmonary embolisms, types of deep vein thrombosis, and the risk of death in the short term.
In minor procedures, coagulation differences may not be clinically significant to determine bleeding or thrombotic periprocedure complication risks.